ATE53490T1 - Arzneipraeparate mit geregelter wirkstoffabgabe. - Google Patents

Arzneipraeparate mit geregelter wirkstoffabgabe.

Info

Publication number
ATE53490T1
ATE53490T1 AT85110631T AT85110631T ATE53490T1 AT E53490 T1 ATE53490 T1 AT E53490T1 AT 85110631 T AT85110631 T AT 85110631T AT 85110631 T AT85110631 T AT 85110631T AT E53490 T1 ATE53490 T1 AT E53490T1
Authority
AT
Austria
Prior art keywords
drug
tablet
active substance
core
regulated release
Prior art date
Application number
AT85110631T
Other languages
English (en)
Inventor
Ake Rikard Lindahl
Bo Magnus Ekman
Original Assignee
Leo Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Ab filed Critical Leo Ab
Application granted granted Critical
Publication of ATE53490T1 publication Critical patent/ATE53490T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Temperature (AREA)
  • Slot Machines And Peripheral Devices (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT85110631T 1984-09-06 1985-08-23 Arzneipraeparate mit geregelter wirkstoffabgabe. ATE53490T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8404467A SE8404467D0 (sv) 1984-09-06 1984-09-06 Controlled-release medical preparations
EP85110631A EP0173928B1 (de) 1984-09-06 1985-08-23 Arzneipräparate mit geregelter Wirkstoffabgabe

Publications (1)

Publication Number Publication Date
ATE53490T1 true ATE53490T1 (de) 1990-06-15

Family

ID=20356934

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85110631T ATE53490T1 (de) 1984-09-06 1985-08-23 Arzneipraeparate mit geregelter wirkstoffabgabe.

Country Status (21)

Country Link
US (1) US4824678A (de)
EP (1) EP0173928B1 (de)
JP (1) JP2527713B2 (de)
KR (1) KR930003114B1 (de)
AT (1) ATE53490T1 (de)
AU (1) AU576891B2 (de)
CA (1) CA1252723A (de)
DE (1) DE3578123D1 (de)
DK (1) DK164256C (de)
ES (1) ES8702138A1 (de)
FI (1) FI87042C (de)
GR (1) GR852158B (de)
HU (1) HU194495B (de)
IE (1) IE58263B1 (de)
IL (2) IL76256A (de)
NO (1) NO169996C (de)
NZ (1) NZ213245A (de)
PH (1) PH22119A (de)
PT (1) PT81092B (de)
SE (1) SE8404467D0 (de)
ZA (1) ZA856547B (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917899A (en) * 1983-12-22 1990-04-17 Elan Corporation Plc Controlled absorption diltiazem formulation
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
US4716041A (en) * 1984-02-10 1987-12-29 A/S Alfred Benzon Diffusion coated multiple-units dosage form
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
US5073381A (en) * 1988-08-15 1991-12-17 University Of Akron Amphiphilic networks
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5178868A (en) * 1988-10-26 1993-01-12 Kabi Pharmacia Aktiebolaq Dosage form
SE8803822D0 (sv) * 1988-10-26 1988-10-26 Novel dosage form
US5149425A (en) * 1988-11-09 1992-09-22 Chembiomed, Ltd. Affinity supports for hemoperfusion
US5240601A (en) * 1988-11-09 1993-08-31 Chembiomed, Ltd. Affinity supports for hemoperfusion
ES2067957T3 (es) * 1990-08-07 1995-04-01 Pfizer Uso de membranas polimerizadas interfacialmente en dispositivos de liberacion.
US5288505A (en) * 1991-06-26 1994-02-22 Galephar P.R., Inc., Ltd. Extended release form of diltiazem
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
ZA933725B (en) * 1992-05-28 1993-12-15 Elan Corp Plc Tablet formulation
AU6358594A (en) * 1993-03-09 1994-09-26 Middlesex Sciences, Inc. Macromolecular microparticles and methods of production
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
EP1005863A1 (de) 1998-12-04 2000-06-07 Synthelabo Dosisformen mit gesteuerter Wirkstofffreigabe enthaltend ein kurzer wirkung Hypnotikum oder einem Salz davon
EP1064937A1 (de) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmazeutische Zusammensetzungen mit kontrollierten Freigabe enthaltend ein Hypnotikum mit kurzer Wirkung oder deren Salze
GB9923045D0 (en) * 1999-09-29 1999-12-01 Novartis Ag New oral formulations
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
WO2001045676A2 (en) 1999-12-20 2001-06-28 Schering Corporation Extended release oral dosage composition
SK287684B6 (sk) 1999-12-20 2011-06-06 Schering Corporation Pevná orálna farmaceutická dávková forma s predĺženým uvoľňovaním
SE0100200D0 (sv) 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
US6960357B2 (en) 2001-05-25 2005-11-01 Mistral Pharma Inc. Chemical delivery device
BR0211317A (pt) * 2001-07-04 2004-12-14 Sun Pharmaceutical Ind Ltd Sistema para a liberação controlada de uma droga por meio de retenção gástrica
US6602911B2 (en) 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
JP2005514386A (ja) * 2001-12-19 2005-05-19 アストラゼネカ・アクチエボラーグ 新規フィルム・コーティング
CA2479350A1 (en) * 2002-03-15 2003-09-25 Cypress Bioscience, Inc. Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
GB0227948D0 (en) * 2002-11-29 2003-01-08 Cipla Ltd Pharmaceutical combinations comprising b-2 adrenoreceptor agonists and xanthines
CA2513893A1 (en) * 2003-01-28 2004-08-12 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US7862835B2 (en) * 2004-10-27 2011-01-04 Boston Scientific Scimed, Inc. Method of manufacturing a medical device having a porous coating thereon
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
ATE438381T1 (de) * 2005-11-18 2009-08-15 Synhton B V Zolpidemtabletten
US7427414B2 (en) * 2006-01-18 2008-09-23 Astron Research Limited Modified release oral dosage form using co-polymer of polyvinyl acetate
CN102440992A (zh) * 2011-12-19 2012-05-09 岳阳新华达制药有限公司 含有盐酸班布特罗和多索茶碱复方制剂及其制备方法
WO2017026950A1 (en) 2015-08-07 2017-02-16 Santa Farma Ilac San. A. S. Controlled release propiverine formulations
EP3796908B1 (de) 2018-11-16 2023-05-10 Santa Farma Ilaç Sanayi A.S. Propiverin-formulierungen mit kontrollierter freisetzung
EP4251154A1 (de) 2020-11-27 2023-10-04 Santa Farma Ilac Sanayii A.S. Propiverin enthaltende formulierungszusammensetzungen mit verzögerter freisetzung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE556141A (de) * 1956-03-27
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
EP0013131A3 (de) * 1978-12-27 1981-01-07 Mundipharma A.G. Pharmazeutische Zusammensetzung in fester Verabreichungsform und Verfahren zu ihrer Herstellung
US4557925A (en) * 1982-07-08 1985-12-10 Ab Ferrosan Membrane-coated sustained-release tablets and method
JPH075457B2 (ja) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド 調節された方法による有効成分の放出を可能にする医薬組成物
US4769027A (en) * 1984-08-15 1988-09-06 Burroughs Wellcome Co. Delivery system

Also Published As

Publication number Publication date
US4824678A (en) 1989-04-25
NO853407L (no) 1986-03-07
GR852158B (de) 1986-01-08
DK164256C (da) 1992-10-19
HU194495B (en) 1988-02-29
ES546728A0 (es) 1986-12-16
PH22119A (en) 1988-06-01
ZA856547B (en) 1986-04-30
DK164256B (da) 1992-06-01
FI853406L (fi) 1986-03-07
DE3578123D1 (de) 1990-07-19
PT81092B (pt) 1988-01-22
ES8702138A1 (es) 1986-12-16
NO169996B (no) 1992-05-25
FI87042B (fi) 1992-08-14
KR860002271A (ko) 1986-04-24
HUT40333A (en) 1986-12-28
NO169996C (no) 1992-09-02
FI87042C (fi) 1992-11-25
EP0173928A1 (de) 1986-03-12
JPS61112013A (ja) 1986-05-30
AU576891B2 (en) 1988-09-08
DK400685A (da) 1986-03-07
IL76256A (en) 1990-06-10
IE58263B1 (en) 1993-08-25
SE8404467D0 (sv) 1984-09-06
DK400685D0 (da) 1985-09-02
EP0173928B1 (de) 1990-06-13
AU4693585A (en) 1986-03-13
IL76256A0 (en) 1986-01-31
KR930003114B1 (ko) 1993-04-19
FI853406A0 (fi) 1985-09-05
IL76257A (en) 1989-05-15
NZ213245A (en) 1988-06-30
CA1252723A (en) 1989-04-18
JP2527713B2 (ja) 1996-08-28
IE852070L (en) 1986-03-06
PT81092A (en) 1985-10-01

Similar Documents

Publication Publication Date Title
ATE53490T1 (de) Arzneipraeparate mit geregelter wirkstoffabgabe.
HUT59321A (en) Process for producing pharmaceutical compositions having controlled release of active ingredient
ATE150963T1 (de) Kugelförmige granula mit kern sowie deren herstellung
KR910011242A (ko) 서방성 약학제제 및 그의 제조방법
IE883810L (en) Sustained release pharmaceutical compositions
ATE229327T1 (de) Verwendung von redispergierbaren polymerpulvern oder polymergranulaten zum überziehen von pharmazeutischen oder agrochemischen darreichungsformen
DE3767600D1 (de) Ibuprofen-formulation mit verzoegerter wirkstoffabgabe.
DE3680450D1 (de) Pharmazeutische zubereitungen von metoprolol mit kontrollierter wirkstoffabgabe, verfahren zu ihrer herstellung und verwendung dieser zubereitungen.
NO20001670L (no) Fremgangsmate for fremstilling av en smaksmaskert farmasoytisk blanding og smaksmaskert farmasoytisk blanding fremstilt ifolge denne fremgangsmaten, samt smaksmaskerte tyggbare tabletter
CA2000932A1 (en) Oral pharmaceutical controlled release multiple unit dosage form
NO170424C (no) Harpikspartikler av desintegrasjonstypen, deres fremstilling og beleggsmiddel inneholdende slike partikler
JPS5318646A (en) Soil conditioner

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee